市场调查报告书
商品编码
1309224
细胞解离市场 - 2018-2028 年全球行业规模、份额、趋势、竞争、机会及预测 按类型、按产品类型、按组织、按最终用户、按地区细分Cell Dissociation Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028 Segmented By Type, By Product Type, By Tissue, By End User, By Region |
在 2024-2028 年的预测期内,全球细胞解离市场预计将以惊人的复合年增长率增长。这主要归因于生物制药行业研究的不断发展、个性化医疗需求的不断增长以及公共和政府对细胞研究投资的不断增加等因素。
慢性疾病在人群中的流行率不断上升,推动了细胞分离技术的市场需求。传染病的日益流行是全世界人民关注的一个主要健康问题。例如,根据世界卫生组织(WHO)的数据,2019 年有 2.96 亿人感染慢性乙型肝炎,每年新增感染人数约 150 万。细胞解离在疾病诊断中有着非常重要的应用,因此在预测期内将促进全球细胞解离市场的增长。例如,细胞解离可分离出核酸、RNA 和 DNA,并进一步分析鉴定载体,进而鉴定疾病。对无细胞 DNA 进行测序可检测出丙型肝炎、艾滋病、乙型肝炎、巨细胞病毒和人类 T 细胞淋巴细胞病毒等传染性疾病。
肿瘤组织中的细胞种类繁多,需要多种基于细胞的分析技术来确定不同细胞亚型的特征。要对肿瘤组织进行进一步研究,需要先用蛋白水解酶将肿瘤组织解离成单细胞,然后使用涡旋或移液技术进行机械分解。微流体设备等技术可用于将消化后的组织集合体解离成单细胞。使用微流体设备可将细胞聚集体快速解离成单细胞,并获得完全存活的细胞。这种使用微流控装置的技术也可在无酶条件下使用。因此,这些方法有助于保护疑似肿瘤组织的单细胞检测和纯化方法,从而扩大研究范围,促进癌症生物学的发展,加强癌症检测中的分子诊断,从而支持预测期内的市场增长。
生命科学的多个领域对细胞解离的需求日益增长,其研究和治疗应用范围十分广泛。一些公司开始进行并购,以推动市场增长。例如,2021 年 3 月,罗氏诊断公司(Roche Diagnostics)宣布与 GenMark 诊断公司(GenMark Diagnostics Inc.通过此次收购,罗氏将获得 GenMark 的 ePlex 平台,该平台是一项尖端创新技术,只需一份患者样本就能检测多种疾病。这项技术的众多用途包括快速诊断细菌和病毒性疾病以及抗生素耐药性。此外,印度、中国、巴西等新兴经济体对生命科学研发的投资增加,也为市场需求提供了支持。例如,印度制药公司 Biocon 在 2020 年增加了研发投入,花费了 5879 万美元。
2022 年,市场领先企业赛默飞世尔科技公司在马斯特里赫特举行的国际质谱会议上推出了专为高端生物制药和蛋白质组应用设计的 Orbitrap Ascend TriBrid 仪器。
根据给定的市场数据,TechSci Research 可根据公司的具体需求提供定制服务。报告可提供以下定制选项:
Global Cell Dissociation Market is expected to grow with an impressive CAGR in the forecast period of 2024-2028. This can be attributed to factors such as growing research in biopharmaceutical industries, growing demand for personalized medicine, and rising public and governmental investments in cell-based research.
Cell dissociation is a significant step in several research applications, such as it is used in developing vaccines and in cell expansion.
Moreover, the rising development in advanced tissue dissociation, increased development & research studies in stem cell research, along with easy differentiation in enzyme-free dissociation products over the enzymatic dissociation products, etc., are factors that are supporting the market growth and are expected to propel it in the forecast period.
The growing prevalence of chronic diseases among the population is propelling the market demand for cell dissociation. The growing prevalence of infectious diseases is a major health concern among people around the world. For instance, according to the World Health Organization (WHO), 296 million people were affected with chronic hepatitis B infection in 2019, with around 1.5 million new infections developing each year. Cell dissociation founds a very significant application in disease diagnosis and thereby adds to the global cell dissociation market growth in the forecast period. For instance, cell dissociation leading to isolation of the nucleic acids, RNA and DNA, is further analyzed for identification of the vector and followed by the identification of the disease. Sequencing of cell-free DNA can result in the detection of infectious diseases such as hepatitis C, HIV, hepatitis B, cytomegalovirus, and human T-cell lymphotropic virus.
Tumor tissues hold a distinct cell range, requiring several cell-based analysis techniques to characterize different cell subtypes. To undergo further research or study of the tumor tissue, it needs to be dissociated into single cells by undergoing treatments with proteolytic enzymes, which is followed by mechanical breakdown using vortexing or pipetting techniques. Techniques such as microfluidic devices are used for the dissociation of digested tissue aggregate into single cells. The microfluidic device usage results in the quick dissociation of cell aggregate into single cells and also results in obtaining cells in fully viable forms. This technique using microfluidic devices can also be used in enzyme-free conditions. These methods thus aid in the protection of single cell detection and purification methods for tumor-suspecting tissue and thereby enhancing the research scope for advancing cancer biology and enhancing molecular diagnosis in cancer detection, thereby supporting the market growth in the forecast period.
There is a growing demand for cell dissociation in multiple fields of life sciences, having a wide range of research and therapeutic applications. Several companies have started mergers and acquisitions to propel the growth of the market. For instance, in March 2021, Roche Diagnostics, announced its partnership with GenMark Diagnostics Inc. Through the acquisition, Roche will have access to GenMark's ePlex platform, a cutting-edge innovation that enables testing for a variety of diseases using just one patient sample. Numerous uses of this technique include the quick diagnosis of bacterial and viral illnesses as well as antibiotic resistance. Additionally emerging economies such as India, China, Brazil, etc. are adding to support the market demand with increased rise in investment in research & development in life sciences. For instance, Indian pharmaceutical company Biocon increased investment and spent USD 58.79 million on research & development in 2020.
In 2022, one of the leading market players, Thermo Fisher Scientific, at the international mass spectroscopy conference in Maastricht, launched the Orbitrap Ascend TriBrid instrument designed for high-end biopharma and proteomic applications.
Global Cell Dissociation Market is segmented based on the type, product type, tissue, end user, region, and competitive landscape. Based on the type, the market is further segmented into tissue dissociation & cell detachment. Based on the product type, the market is segmented into enzymatic dissociation products, non-enzymatic dissociation products, and instruments & accessories. Based on tissue, the market is further fragmented into epithelial tissue, connective tissue, and others. Depending on the end user, the market is segmented into Biotechnology Companies, Pharmaceutical Companies, Academic and Research Institutes, and others. Based on the region, the Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.
BD Biosciences, Miltenyi Biotec, Thermo Fisher Scientific, GE Healthcare, Sartorius Group, Lonza, Danaher Corporation, Merck KGaA, STEMCELL Technologies, and QIAGEN., etc.., are some of the major players operating in the Global Cell Dissociation Market.
In this report, Global Cell Dissociation Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in Global Cell Dissociation Market.
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: